Cintas Beats And Raises Guidance, Preps For Growth
Cintas NASDAQ: CTAS is not immune to the impacts of inflation and supply chain issues but those issues are symptoms of an otherwise strong economy. An economy that is creating new jobs at a record pace, has employment at record levels and driving business for Cintas. While the results could have been stronger in relation to the analysis estimates we’re not reading too much into that comparison. The 50 basis points of outperformance is nothing to brag about but is versus a very high bar. The key takeaway is that revenue and earnings are growing and fueling a very healthy capital return plan. That, plus the obvious strength within the industry, should be enough to keep Cintas setting new all-time highs in 2022 just like it did in 2021.
Cintas Posts Record Quarter
Cintas had a great quarter in which revenue grew 9.4% versus last year and set a new company record. The $1.92 billion is also up 4.30% from 2019 and beat the Marketbeat.com consensus estimate by 50 basis points. Growth was driven by a 9.3% increase in organic business coupled with a 0.1% tailwind related to prior acquisitions. On a segment basis, the core Uniform segment grew by 8.8% while the Other category, which includes fire, first aid, and safety products, grew a more robust 11.7%.
Moving down to the earnings, the company experienced some margin contraction but not in the way you might think. The gross margin contracted by 70 basis points and the operating margin by 30 on investment in employment related to growth plans. On an adjusted basis, however, accounting for the sale of an asset in the previous year, the company’s operating margin expanded by 70 basis points. Regardless, the $2.76 in GAAP earnings is up $0.39 from last year and beat the Marketbeat.com consensus estimate by $0.14. Better, the company is expecting both revenue and margin strength to continue into the end of the year and has raised guidance because of it.
The only catch is that the new guidance is bracketing the consensus estimate in a way that leaves the door open to underperformance in the back half of the year. The company is projecting $7.63 to $7.7 billion in consolidated revenue compared to the $7.66 billion consensus with EPS in the range of $10.60 to $10.90 compared to the $10.90 consensus.
Cintas Is A Dividend Grower
Cintas isn’t a high-yielding stock with a payout of 0.87% but it is a very reliable and safe payout, and one with an expectation for aggressive growth. The company has been increasing the payout annually for over 10 years with a 20% CAGR and there is room in the numbers for this to continue. Not only are revenue and earnings growing, but the balance sheet is rock-solid and the free cash flow is ample. In our view, investors should be ready for another increase at the end of the fiscal year if there is not one before then.
The Technical Outlook: Cintas Pulls Back To Support
Shares of Cintas have been pulling back recently after hitting a fresh all-time high in early December. Price action is moving lower in the wake of the guidance increase and may fall even further if support doesn’t kick in at the $425 level. If price action falls below this level it could continue down to $420 or $400 before finding strong support. If, however, price action is able to hold support at $425 we see sideways to upward action developing with the chance of new all-time highs in early 2022.
Before you consider Cintas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cintas wasn't on the list.
While Cintas currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.